ELLXF News and Press, Elixinol Global Ltd From 02/05/20

Despite the precarious summer cannabis stocks faced last year, an analyst has noted that “equity markets (are) rebounding,” causing an upswing across the sector, including options in Australia. In a note sent to investors on January 22, Cameron Bell, analyst with boutique bank ...

The increased popularity of cannabidiol (CBD) has allowed markets for the extract to pop up across the globe, and Australia is no exception. CBD, a derivative found in the cannabis plant, is now used in everything from pain relief medication to topical face creams, creating a lucrative inves...

The Australian legalization of medical cannabis in 2016 launched a flood of companies to the Australian Stock Exchange (ASX), leading investors to ask just which cannabis stocks to watch on the ASX. Australia’s marijuana sector is young, but with a growing patient base and the possi...

Source: Author based on company filings. Summary The CBD market is expected to boom over the next several years. After being fully legalized by the Farm Bill, the next step for CBD will be when the FDA issues guidelines clarifying the sale and marketing of CBD products for human consum...

Elixinol Global (ASX: EXL ,OTCQX:ELLXF) has discovered that non-compliant hemp-derived cannabidiol (CBD) products were being sold by its subsidiary Elixinol Japan. Last Wednesday (October 23), the New South Wales-based cannabis company informed investors that the breach was found during a ...

Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Cannabis stocks reported solid gains last week. Horizons Marijuana Life Sciences Index ETF ( HMLSF ) rose 4.7%, ETFMG Alternative H...

Play Video Joy Beckerman, regulatory officer and industry liaison with Elixinol, a subsidiary of Elixinol Global (ASX: EXL ,OTCQX:ELLXF), believes consumers feel more comfortable buying hemp products from esta...

CBD is one of the highest potential markets out there at the moment, with many analysts predicting its value to exceed $20 billion USD by 2024. One of the main factors for this huge expansion is the versatility of CBD as a product. Whether it’s CBD vape juice, infused hand cream, g...

Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Cannabis stocks saw a slight rebound last week. The Horizons Marijuana Life Sciences Index ETF ( OTC:HMLSF ) rose 3.2% and the ETFM...

DENVER, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Elixinol , one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced its latest product made in partnership with PharmaCare . Created in partnership with the prominent UK-...